Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • We guide you
    • Fertility
      • What to do if…
    • Prevent Inherited Diseases
      • Carrier Genetic Test
    • Worry-free Pregnancy
      • NACE
      • Prenatal Diagnostics
      • Newborn Health
  • Reproductive Health
    • Specialists
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • Zenit
      • PGT-A
      • PGT-M
      • POC
      • SAT
      • Newborn Screening
    • Patients
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • Zenit
      • PGT-A
      • PGT-M
      • SAT
      • POC
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genetic Solutions > SAT

SAT Sperm aneuploidy test

Analysis of chromosomal abnormalities in sperm

SAT Sperm aneuploidy test
  • Technical Overview
  • Documentation
  • Scientific evidence
  • I’m not a health specialist
igenomix

Up to 60% of pregnancies miscarry due to sperm chromosomal abnormalities

POC Products of Conception

Results compared with internal control to assure highest reliability

SAT Sperm aneuploidy test

SAT provides personalized genetic counseling to the infertile couple before an IVF treatment

SAT Sperm aneuploidy test

Up to 2,000 spermatozoon analyzed for each chromosome

Interested in learning more?

Request information
Or Email us at supportspain@igenomix.com
Overview
  • SAT
  • Benefits
  • Indications

What is SAT test?

  • The Sperm Aneuploidy Test (SAT) is a test to study the genetic factor of male infertility.
  • It allows for the evaluation of the presence of an abnormal number of chromosomes (aneuploidy and diploidy) in the sperm.
  • The chromosomes 13, 18, 21, X and Y, are most frequently implicated in spontaneous miscarriages and affected offspring with chromosomal abnormalities. In SAT, these chromosomes are analysed by fluorescence in situ hybridization (FISH).

What is the procedure?

SAT Sperm aneuploidy test

Why should use SAT test?

An increase of sperm chromosomal abnormalities affects your reproductive journey at three levels:

SAT Sperm aneuploidy test

EMBRYO LEVEL:

  • Spermatozoa with sex chromosome abnormalities results in aneuploid embryos
  • Diploid sperm results in triploid embryos

Rodrigo et al., 2010.

SAT Sperm aneuploidy test

PREGNANCY LEVEL:

  • An altered SAT decreases pregnancy rate after ICSI and increases miscarriage rate

Rubio et al., 2001.

SAT Sperm aneuploidy test

OFFSPRING LEVEL:

  • Sperm chromosomal abnormalities increase the risk of abnormal offspring for the chromosomes affected in the sperm (Down, Klinefelter or Turner’s Syndromes)
SAT Sperm aneuploidy test

Who should use SAT test?

  • Men with a low sperm concentration, who typically have a higher incidence of sperm chromosome abnormalities
  • Couples who have suffered recurrent miscarriage of unknown origin
  • Couples who have experienced repeated implantation failure
  • Couples with a previous pregnancy with a chromosomal abnormality
SAT Sperm aneuploidy test

Test limitations

This technique allows the detection of aneuploidy only for the chromosomes included in the test (13, 18, 21, X and Y). In very few ejaculated samples or testicular samples, there is not enough spermatozoa for a proper estimation of the risk of aneuploidy.

Documentation
  • SAT Specialists’ documents

Clinical Sheets

Download

Instructions

Download
Scientific evidence

Relevant related studies:

Rodrigo L, Peinado V, Mateu E, Remohí J, Pellicer A, Simón C, Gil-Salom M, Rubio C. Impact of different patterns of sperm chromosomal abnormalities on the chromosomal constitution of preimplantation embryos. Fertil Steril. 2010 Sep; 94(4):1380-6.

Rubio C, Gil-Salom M, Simón C, Vidal F, Rodrigo L, Mínguez Y, Remohí J, Pellicer A. Incidence of sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSI outcome. Hum Reprod. 2001 Oct; 16(10):2084-92. 

Rodrigo L, Mateu E, Mercader A, Cobo A, Peinado V, Milán M, Al-Asmar N, Campos-Galindo I, García-Herrero S, Mir P, Simón C, Rubio C. New tools for embryo selection: comprehensive chromosome screening by array comparative genomic hybridization. BioMed
Research International. 2014; In Press. 

FAQs

Opening hours, contact details, lab address...

User manual

If you're a little lost with this technical information...

Can we help you?

I’m not a health specialist

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

Learn more about Igenomix

Other services

PGT-A Preimplantation Genetic Testing

PGT-A

Chromosomally normal
embryos selection

More information

ERA

Evaluates the endometrial receptivity

More information
EndomeTRIO

EndomeTRIO

A new dimension of endometrial health

More information

Igenomix is in the media

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
Country/Region

[2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

Request Information


  • We guide you
    • Fertility
      • What to do if…
    • Prevent Inherited Diseases
      • Carrier Genetic Test
    • Worry-free Pregnancy
      • NACE
      • Prenatal Diagnostics
      • Newborn Health
  • Reproductive Health
    • Specialists
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • Zenit
      • PGT-A
      • PGT-M
      • POC
      • SAT
      • Newborn Screening
    • Patients
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • Zenit
      • PGT-A
      • PGT-M
      • SAT
      • POC
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

International
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy